Capital Research Global Investors reports 13.1% Halliburton (HAL) stake
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
Capital Research Global Investors filed an amended Schedule 13G showing a large ownership stake in Halliburton Co. common stock. It reports beneficial ownership of 110,276,085 shares, representing 13.1% of Halliburton’s 841,626,610 shares believed to be outstanding.
The firm reports sole voting power over 110,264,733 shares and sole dispositive power over 110,276,085 shares, with no shared voting or dispositive power. The securities are described as acquired and held in the ordinary course of business, not for the purpose of changing or influencing control of Halliburton.
Positive
- None.
Negative
- None.
FAQ
What percentage of Halliburton (HAL) does Capital Research Global Investors report owning?
Capital Research Global Investors reports beneficial ownership of 13.1% of Halliburton’s common stock. This corresponds to 110,276,085 shares out of 841,626,610 Halliburton shares believed to be outstanding, as stated in the ownership section of the Schedule 13G/A filing.
Does Capital Research Global Investors seek to influence control of Halliburton (HAL)?
The certification states the securities were acquired and are held in the ordinary course of business, and not for the purpose, or with the effect, of changing or influencing control of Halliburton, nor in connection with any transaction having that control-related purpose or effect.
What type of filing did Capital Research Global Investors make regarding Halliburton (HAL)?
Capital Research Global Investors filed an Amendment No. 2 to Schedule 13G concerning Halliburton common stock. A Schedule 13G/A is a beneficial ownership report used when investors hold more than 5% of a class of registered equity securities under specified conditions.